BamSEC and AlphaSense Join Forces
Learn More

ReShape Lifesciences Inc.

NASDAQ: RSLS    
Share price (1/7/25): $4.70    
Market cap (1/7/25): $3.350 million

Material Contracts Filter

EX-10.26
from S-1 44 pages Equity Purchase Agreement
12/34/56
EX-10.32
from S-4/A 18 pages Development & Licensing Agreement
12/34/56
EX-10.31
from S-4/A 3 pages Addendum to Supply and Marketing Agreement
12/34/56
EX-10.30
from S-4/A 3 pages To, Sun Pharmaceutical Industries Limited Sun House, 201 8/1, Western Express Highway, Goregaon East, Mumbai- 400063 ​ Sub: Consent to Assignment Ref: Supply and Marketing Agreement Dated 10th Day of October, 2016 Read With Assignment Agreement Dated 15th October, 2016 Executed Between Vyome Biosciences Private Limited (“Company”) and Sun Pharmaceutical Industries Limited (“Sun”) (Hereinafter Referred to as (“Agreement”). ​ Dear Sir/Madam, ​
12/34/56
EX-10.29
from S-4/A 20 pages Supply and Marketing Agreement
12/34/56
EX-10.7
from 8-K 6 pages Leak-Out Agreement
12/34/56
EX-10.6
from 8-K 5 pages ReShape Lifesciences Inc. - Lock-Up Agreement
12/34/56
EX-10.5
from 8-K 7 pages This Guaranty (This “Guaranty”), Dated as of October 16, 2024, by ReShape Lifesciences Inc., a Delaware Corporation (Together With Its Successors And, if Permitted, Assigns, the “Company”) and Each of the Other Entities Listed on the Signature Pages Hereof as Guarantor or That Becomes a Party Hereto as Such Pursuant to Section 2.4 (Together With Their Successors And, if Permitted, Assigns and the Company, the “Guarantors”), in Favor of , a Delaware Limited Liability Company, as Collateral Agent (In Such Capacity, and Together With Its Successors And, if Permitted, Assigns, the “Collateral Agent”) Under the Purchase Agreement (As Defined Below), the Holders (Together With Their Successors And, if Permitted, Assigns, the “Holders” or the “Purchasers”) of the Notes Issued and Sold by the Company Pursuant To, the Securities Purchase Agreement, Dated as of October 16, 2024, by and Among the Company and the Holders (The “Purchase Agreement”) and the Other Purchaser Parties (As Defined in the Purchase Agreement). Capitalized Terms Used but Not Defined Herein Are Used as Defined in the Purchase Agreement Or, if Not Defined Therein, Encompass All Items Covered by the Definition of Such Term in Any Note
12/34/56
EX-10.4
from 8-K 31 pages Security Agreement
12/34/56
EX-10.3
from 8-K 18 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 26 pages Senior Secured Convertible Promissory Note Due January 16, 2025
12/34/56
EX-10.1
from 8-K 55 pages Securities Purchase Agreement
12/34/56
EX-10.28
from S-4 ~1 page ​ ​ ​ Vadodara – 390021 Corporate Office: ​ Area, New Delhi: 110 092 (India) ​ ​ Vyome Therapeutics Limited Registered Office: C4-201, Akshar Pavilion, Vadodara – 390021 Corporate Office: Plot No. 465, Gf, Patparganj Industrial Area, New Delhi: 110 092 (India) Cin – U73100gj2017plc098900 ​
12/34/56
EX-10.27
from S-4 2 pages Rent Agreement
12/34/56
EX-10.26
from S-4 2 pages Material contract
12/34/56
EX-10.25
from S-4 2 pages Material contract
12/34/56
EX-10.24
from S-4 6 pages Lease Deed ​
12/34/56
EX-10.23
from S-4 6 pages Lease Deed
12/34/56
EX-10.22
from S-4 7 pages Consulting Agreement
12/34/56
EX-10.21
from S-4 2 pages June 27, 2024 Ambassador Frank Wisner Re: Board Member for Vyome Therapeutics, Inc. Dear Frank
12/34/56